Patients identifying as non-Hispanic Latino (when compared to Hispanic Latino patients) or “Other” race (when compared to White patients) had higher prevalence of PD-1 inhibitor-associated polyneuropathy. The gene discussed is PDCD1; the disease is polyneuropathy.